Successful Drug Discovery
Wiley-VCH (Verlag)
978-3-527-34468-0 (ISBN)
Janos Fischer, PhD, is a Senior Research Scientist at Richter Plc., Budapest, Hungary, and is Chair of the Subcommittee on Drug Discovery and Development of IUPAC. Christian Klein, PhD, is Head of Oncology Programs at the Roche Innovation Center Zurich, specialized in the discovery, validation and preclinical development of antibody based cancer immunotherapies and bispecific antibodies. Wayne Childers, PhD, is Associate Professor of Pharmaceutical Sciences at Temple University, Philadelphia, USA.
PART 1: General Aspects
Trends in Peptide-based Drug Discovery
Physicochemical Parameters of Recently Approved Oral Drugs
PART 2: Drug Class Studies
Antibody-Drug Conjugates: Empowering Antibodies for the Fight against Cancer
Dopamine Partial Agonists - Discovery, Evolution and Therapeutic Potential
PART 3: Case Studies
Discovery of Etelcalcetide for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease
Development of Lenvatinib Mesylate, an Angiogenesis Inhibitor Targeting VEGF and FGF Receptors
Ocrelizumab : A New Generation of anti-CD-20 mAb for the Treatment of Multiple Sclerosis
The Story of Rucaparib/Rubraca
Discovery and Development of Venetoclax, a Selective Antagonist of Bcl-2
Erscheinungsdatum | 18.09.2019 |
---|---|
Verlagsort | Weinheim |
Sprache | englisch |
Maße | 170 x 244 mm |
Gewicht | 692 g |
Themenwelt | Medizin / Pharmazie ► Pharmazie |
Naturwissenschaften ► Chemie | |
Schlagworte | Chemie • Chemistry • Drug Discovery & Development • Medical Science • Medizin • Organic Chemistry • Organische Chemie • Pharmacology & Pharmaceutical Medicine • Pharmakologie • Pharmakologie u. Pharmazeutische Medizin • Wirkstoffforschung • Wirkstoffforschung u. -entwicklung |
ISBN-10 | 3-527-34468-3 / 3527344683 |
ISBN-13 | 978-3-527-34468-0 / 9783527344680 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich